Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome: genes and variants
Explore variant evidence for Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome across 1 analyzed protein (PDGFRB). Linked ClinVar records include 4 pathogenic or likely pathogenic variants, 71 variants of uncertain significance and 24 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome
PDGFRB: Platelet-derived growth factor receptor beta
Its signaling supports pericytes, vascular smooth-muscle cells, and other mesenchymal lineages during growth and tissue repair. Oncogenic fusions drive myeloid neoplasms, while germline activating or loss-of-function variants can cause developmental and vascular disorders.
4 ClinVar pathogenic / likely pathogenic and 95 uncertain variants in PDGFRB have source records linked to Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| PDGFRB P560L | 560 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| PDGFRB P584R | 584 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| PDGFRB A342V | 342 | Ig-like C2-type 4 | Pathogenic / likely pathogenic (★) |
| PDGFRB A828E | 828 | Protein kinase | Pathogenic / likely pathogenic (★) |
Same protein, different disease
- Myofibromatosis also has ClinVar records linked to PDGFRB variants; they fall mostly in different places as the Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome variants (10 pathogenic / likely pathogenic).
- Acroosteolysis-keloid-like lesions-premature aging syndrome also has ClinVar records linked to PDGFRB variants; they fall mostly in different places as the Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome variants (6 pathogenic / likely pathogenic).
Diseases related to Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome
- Gastrointestinal stromal tumor, also linked to PDGFRB
- Acute myeloid leukemia, also linked to PDGFRB
- Myofibromatosis, also linked to PDGFRB
- Colorectal cancer, also linked to PDGFRB
- Non-small cell lung carcinoma, also linked to PDGFRB
- Idiopathic pulmonary fibrosis, also linked to PDGFRB
- Acroosteolysis-keloid-like lesions-premature aging syndrome, also linked to PDGFRB
- Hepatocellular carcinoma, also linked to PDGFRB
- Acute lymphoid leukemia, also linked to PDGFRB
- Renal cell carcinoma, also linked to PDGFRB
- Chronic myeloid leukemia, also linked to PDGFRB
- Basal ganglia calcification, idiopathic, 4, also linked to PDGFRB
Frequently asked questions
Which genes have records linked to Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome?
This view contains 1 analyzed proteins: PDGFRB. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 4 pathogenic or likely pathogenic variants, 71 variants of uncertain significance and 24 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 154 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center